Latest Breaking News On - Scientific session - Page 1 : comparemela.com

American Society of Echocardiography Scientific Sessions ASE 2024 Program Highlights

Novel PCSK9 Inhibitor Reduced LDL by 50%

Lerodalcibep, a third-generation PCSK9 inhibitor, reduced LDL by more than 50% vs placebo in patients with or at a high risk for CVD in the phase 3 LIBerate-HR trial.

Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events

Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.

Complete Revasc Not Superior to Culprit-Only PCI After MI

In patients with STEMI and multivessel disease, FFR-guided complete nonculprit revascularization did not reduce events vs culprit lesion-only PCI in the FULL-REVASC trial.

Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicity

The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury.